The Iwakura Mission in Britain, 1872

In London, at the Suntory and Toyota International Centres for Economics and Related Disciplines (LSE), a symposium was held on 6 December 1997 - the anniversary of the day when the members of Iwakura's delegation were received by Queen Victoria. Comprising four lectures the symposium was attended by a packed audience of some 75 people including the Joint Chairman and many members of the Japan Society, several senior representatives of the Japanese Embassy, as well as staff and students. Each lecturer focused sharply on a particular aspect of the Mission's work in Britain that fell within his or her special field and each prompted numerous questions and much discussion. It is some measure of the great range of subjects that the Mission was attempting to cover that there was no real overlap between any of the four papers. They are now included in their entirety in this volume.Iwakura misson, Victorian London, Kume Kunitake, Iwakura Tomomi, Ito Hirobumi, education, industry, exports, religion, Kairan Jikki chronicle, Meiji government, unequal treaties, embassy, 1872, Britain, Japan, America.

On Open and Strong-Scaling Tools for Atom Probe Crystallography: High-Throughput Methods for Indexing Crystal Structure and Orientation

Volumetric crystal structure indexing and orientation mapping are key data processing steps for virtually any quantitative study of spatial correlations between the local chemistry and the microstructure of a material. For electron and X-ray diffraction methods it is possible to develop indexing tools which compare measured and analytically computed patterns to decode the structure and relative orientation within local regions of interest. Consequently, a number of numerically efficient and automated software tools exist to solve the above characterisation tasks. For atom probe tomography (APT) experiments, however, the strategy of making comparisons between measured and analytically computed patterns is less robust because many APT datasets may contain substantial noise. Given that general enough predictive models for such noise remain elusive, crystallography tools for APT face several limitations: Their robustness to noise, and therefore, their capability to identify and distinguish different crystal structures and orientation is limited. In addition, the tools are sequential and demand substantial manual interaction. In combination, this makes robust uncertainty quantifying with automated high-throughput studies of the latent crystallographic information a difficult task with APT data. To improve the situation, we review the existent methods and discuss how they link to those in the diffraction communities. With this we modify some of the APT methods to yield more robust descriptors of the atomic arrangement. We report how this enables the development of an open-source software tool for strong-scaling and automated identifying of crystal structure and mapping crystal orientation in nanocrystalline APT datasets with multiple phases.Comment: 36 pages, 19 figures, preprin

Live strong and prosper: the importance of skeletal muscle strength for healthy ageing

Due to improved health care, diet and infrastructure in developed countries, since 1840 life expectancy has increased by approximately 2years per decade. Accordingly, by 2050, a quarter of Europe’s population will be over 65years, representing a 10% rise in half a century. With this rapid rise comes an increased prevalence of diseases of ageing and associated healthcare expenditure. To address the health consequences of global ageing, research in model systems (worms, flies and mice) has indicated that reducing the rate of organ growth, via reductions in protein synthetic rates, has multi-organ health benefits that collectively lead to improvements in lifespan. In contrast, human pre-clinical, clinical and large cohort prospective studies demonstrate that ageing leads to anabolic (i.e. growth) impairments in skeletal muscle, which in turn leads to reductions in muscle mass and strength, factors directly associated with mortality rates in the elderly. As such, increasing muscle protein synthesis via exercise or protein-based nutrition maintains a strong, healthy muscle mass, which in turn leads to improved health, independence and functionality. The aim of this review is to critique current literature relating to the maintenance of muscle mass across lifespan and discuss whether maintaining or reducing protein synthesis is the most logical approach to support musculoskeletal function and by extension healthy human ageing

A comparison of broad-spectrum and narrow-spectrum dry cow therapy used alone and in combination with a teat sealant

The dry period is a critical time in the lactation cycle, offering the optimum time for cure of existing intramammary infection (IMI), while also encompassing the periods of highest susceptibility to new intramammary infection. Until recent years, intramammary infection in the dry period has been controlled with the use of antibiotic dry cow therapy. The aim of this study was to investigate 3 different dry cow therapy regimens, in low-somatic cell count (SCC; bulk milk SCC < 250,000 cells/mL) herds in southwest England. A total of 489 cows was recruited to the study and randomly allocated to receive either the broad-spectrum antibiotic cefquinome, a combination treatment comprising the narrow-spectrum antibiotic cloxacillin and an internal teat sealant, or the narrow-spectrum antibiotic cloxacillin alone. All quarters were sampled for bacteriology at drying off and again in the week immediately postcalving; 2 quarters were also sampled 2 wk before the estimated calving date to allow an assessment of infection dynamics during the dry period. Quarters were subsequently monitored for clinical mastitis for the first 100 d of lactation. Conventional multilevel (random effects) models were constructed to assess the efficacy of products in preventing IMI. Survival analysis was used to examine factors that influenced the risk of clinical mastitis using conventional Cox proportional hazards models. No differences were identified between the treatment groups in terms of cure of IMI caused by the major pathogens. Quarters in both the combination and cefquinome-treated groups were more likely to be free of a major pathogen or enterobacterial pathogen postcalving. With respect to clinical mastitis, the cefquinome-treated group was less likely to develop clinical mastitis than was the cloxacillin treated group

Accurate OH maser positions II. the Galactic Center region

We present high spatial resolution observations of ground-state OH masers, achieved using the Australia Telescope Compact Array (ATCA). These observations were conducted towards 171 pointing centres, where OH maser candidates were identified previously in the Southern Parkes Large-Area Survey in Hydroxyl (SPLASH) towards the Galactic Center region, between Galactic longitudes of $355^{\circ}$ and $5^{\circ}$ and Galactic latitudes of $-2^{\circ}$ and $+2^{\circ}$. We detect maser emission towards 162 target fields and suggest that 6 out of 9 non-detections are due to intrinsic variability. Due to the superior spatial resolution of the follow-up ATCA observations, we have identified 356 OH maser sites in the 162 of the target fields with maser detections. Almost half (161 of 356) of these maser sites have been detected for the first time in these observations. After comparing the positions of these 356 maser sites to the literature, we find that 269 (76\%) sites are associated with evolved stars (two of which are planetary nebulae), 31 (9\%) are associated with star formation, four are associated with supernova remnants and we were unable to determine the origin of the remaining 52 (15\%) sites. Unlike the pilot region (\citealt{Qie2016a}), the infrared colors of evolved star sites with symmetric maser profiles in the 1612 MHz transition do not show obvious differences compared with those of evolved star sites with asymmetric maser profiles.Comment: 24 pages, 12 figures, accepted by ApJ

Focused Ion Beam induced hydride formation does not affect Fe, Ni, Cr-clusters in irradiated Zircaloy-2

Room temperature focused ion beam (FIB) milling is known to potentially promote the formation of hydrides in zirconium and its alloys. We used atom probe tomography (APT) to determine the composition of irradiated and as-produced Zircaloy-2 fuel cladding. We consistently found ∼ 50 at% hydrogen in all room temperature FIB-milled specimens run in voltage pulsing APT measurements. Crystallographic analysis of APT data however showed slightly better agreement with δ-hydride (ZrH2, FCC, ∼ 60–66.7 at% H) than γ-hydride (ZrH, FCT, ∼ 50 at% H). Electron energy loos spectroscopy (EELS) measurements prior to APT analyses confirmed the presence of δ-hydride. Hence, APT gives a systematic underestimation of hydrogen for Zr-hydride. Milling at cryogenic temperatures was found to not cause such hydride formation. However, we did not find significant differences in the clusters formed by segregation of the alloying elements Fe, Cr and Ni to irradiation induced a-loops whether the material was identified as α-Zr or hydride. Therefore, analyzing irradiation-induced redistribution of alloying elements in Zr fuel cladding using APT does not rely on FIB preparation at cryogenic temperatures. However, in conjunction with voltage pulsing APT cryo-FIB can be worthwhile if one aims at investigating hydrogen distribution or hydrides

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation

Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare. Treatment for liver metastases has largely been surgical resection, but this is feasible in only approximately 20–30% of people. Non-surgical alternatives to treat some liver metastases can include various forms of ablative therapies and other targeted treatments.Objectives: To evaluate the clinical effectiveness and cost-effectiveness of the different ablative and minimally invasive therapies for treating liver metastases.Data sources: Electronic databases including MEDLINE, EMBASE and The Cochrane Library were searched from 1990 to September 2011. Experts were consulted and bibliographies checked.Review methods: Systematic reviews of the literature were undertaken to appraise the clinical effectiveness and cost-effectiveness of ablative therapies and minimally invasive therapies used for people with liver metastases. Studies were any prospective study with sample size greater than 100 participants. A probabilistic model was developed for the economic evaluation of the technologies where data permitted.Results: The evidence assessing the clinical effectiveness and cost-effectiveness of ablative and other minimally invasive therapies was limited. Nine studies of ablative therapies were included in the review; each had methodological shortcomings and few had a comparator group. One randomised controlled trial (RCT) of microwave ablation versus surgical resection was identified and showed no improvement in outcomes compared with resection. In two prospective case series studies that investigated the use of laser ablation, mean survival ranged from 41 to 58 months. One cohort study compared radiofrequency ablation with surgical resection and five case series studies also investigated the use of radiofrequency ablation. Across these studies the median survival ranged from 44 to 52 months. Seven studies of minimally invasive therapies were included in the review. Two RCTs compared chemoembolisation with chemotherapy only. Overall survival was not compared between groups and methodological shortcomings mean that conclusions are difficult to make. Two case series studies of laser ablation following chemoembolisation were also included; however, these provide little evidence of the use of these technologies in combination. Three RCTs of radioembolisation were included. Significant improvements in tumour response and time to disease progression were demonstrated; however, benefits in terms of survival were equivocal. An exploratory survival model was developed using data from the review of clinical effectiveness. The model includes separate analyses of microwave ablation compared with surgery and radiofrequency ablation compared with surgery and one of radioembolisation in conjunction with hepatic artery chemotherapy compared with hepatic artery chemotherapy alone. Microwave ablation was associated with an incremental cost-effectiveness ratio (ICER) of £3664 per quality-adjusted life-year (QALY) gained, with microwave ablation being associated with reduced cost but also with poorer outcome than surgery. Radiofrequency ablation compared with surgical resection for solitary metastases &lt; 3 cm was associated with an ICER of –£266,767 per QALY gained, indicating that radiofrequency ablation dominates surgical resection. Radiofrequency ablation compared with surgical resection for solitary metastases ? 3 cm resulted in poorer outcomes at lower costs and a resultant ICER of £2538 per QALY gained. Radioembolisation plus hepatic artery chemotherapy compared with hepatic artery chemotherapy was associated with an ICER of £37,303 per QALY gained.Conclusions: There is currently limited high-quality research evidence upon which to base any firm decisions regarding ablative therapies for liver metastases. Further trials should compare ablative therapies with surgery, in particular. A RCT would provide the most appropriate design for undertaking any further evaluation and should include a full economic evaluation, but the group to be randomised needs careful selection.Source of funding: Funding for this study was provided by the Health Technology Assessment programme of the National Institute for Health Research